Economic Cost of Smoking in People with Mental Disorders in the UK
Overview
Affiliations
Background: Smoking is the largest preventable cause of death in the UK and imposes a huge economic burden on society. Both the prevalence and extent of smoking are significantly higher among people with mental disorders than among the general population.
Aims: To estimate the economic costs of the health effects of cigarette smoking among people with mental disorders in the UK from a societal perspective.
Methods: This study uses the WHO's economics of tobacco toolkit to assess the costs of the health effects of cigarette smoking among people with mental disorders in 2009/10 in the UK. Based on the cost of illness approach, direct healthcare costs, indirect morbidity costs and indirect mortality costs due to smoking-related diseases were calculated to estimate the avoidable economic burden of smoking in people with mental disorders.
Results: The estimated economic cost of smoking in people with mental disorders was £2.34 billion in 2009/10 in the UK, of which, about £719 million (31% of the total cost) was spent on treating diseases caused by smoking. Productivity losses due to smoking-related diseases were about £823 million (35%) for work-related absenteeism and £797 million (34%) was associated with premature mortality.
Conclusions: Smoking in people with mental disorders in the UK imposes significant economic costs. The development and implementation of smoking cessation interventions in this group should therefore be a high economic and clinical priority.
Economic burden of cancer attributable to modifiable risk factors in Japan.
Saito E, Tanaka S, Abe S, Hirayabashi M, Ishihara J, Katanoda K Glob Health Med. 2023; 5(4):238-245.
PMID: 37655182 PMC: 10461334. DOI: 10.35772/ghm.2023.01001.
Wu Q, Gilbody S, Li J, Wang H, Parrott S Value Health. 2021; 24(9):1263-1272.
PMID: 34452705 PMC: 8404974. DOI: 10.1016/j.jval.2021.04.002.
Mental health and smoking cessation-a population survey in England.
Brose L, Brown J, McNeill A BMC Med. 2020; 18(1):161.
PMID: 32580770 PMC: 7315517. DOI: 10.1186/s12916-020-01617-7.
Lappin J, Thomas D, Curtis J, Blowfield S, Gatsi M, Marr G Medicina (Kaunas). 2020; 56(4).
PMID: 32344790 PMC: 7231207. DOI: 10.3390/medicina56040204.
Sweeney R, Moodie M, Baker A, Borland R, Castle D, Segan C Front Psychiatry. 2019; 10:618.
PMID: 31551827 PMC: 6735263. DOI: 10.3389/fpsyt.2019.00618.